AzTrials
AzTrials

Reflex Sympathetic DystrophyAlgoMIRNCT02667717

Efficacy and Safety of a Learning Program of Self- Rehabilitation Exercises by Mirror Therapy

A study testing Mirror therapy in people with Reflex Sympathetic Dystrophy and Causalgia, run by Centre Hospitalier Universitaire de Saint Etienne at 5 sites in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

AlgoMIR project born thanks to a meeting between pain professionals and re-education staff. The goal of this project is to develop and evaluate a program of learning with exercises by mirror therapy, that could be easily shared with paramedic teams and easily adapted to different handicaps. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Reflex Sympathetic Dystrophy, Causalgia
What is being tested?
Mirror therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
5 sitesFrance
Study dates
6 Jun 2017to 6 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Affiliation to Social Security
  • CRPS (complex regional pain syndrome) type I or II defined by the criteria of Bruehl (Table 1)
  • CRPS of the upper limb including the wrist and / or hand
  • CRPS post-surgical or post-traumatic
  • Average pain in the last 24 hours of intensity > = 30/100 on EVA (0 no pain, 100: worst pain imaginable )
  • Evolution for over 3 months and less than 2 years
  • Patients taking a stable background therapy for 15 days and not having received the following treatments in the previous months : bisphosphonate cure, infiltration, Qutenza, ketamine infusions
  • Patients accepting a rehabilitation (physiotherapists or hospital units for patients included on Saint-Etienne and hospital units for patients included in Lyon and Saint- Vallier)

Who cannot join

  • CRPS post stroke or drug
  • Adhesive capsulitis isolated
  • Cognitive or language difficulties preventing understanding instructions and / or a correct clinical evaluation
  • Patient who already received a rehabilitation program with the use of mirror therapy or other virtual reality technology
  • CRPS in connection with an accident caused by a third party for which a legal procedure is underway
  • Major Depressive Episode
  • Dissociative Disorders
  • Visually impaired patients

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

France5 sites
  • MPR des Massues

    Lyon, 69000

  • Centre médical de l'Argentière

    Saint-Etienne, 42100

  • Chu Saint Etienne

    Saint-Etienne, 42100

  • Consultation Douleur de la Mutualité de la Loire

    Saint-Etienne

  • MPR de l'Hôpital Drôme Nord

    Saint-Vallier

Other trials in France

About this study

Official title: Efficacy and Safety of a Learning Program of Self- Rehabilitation Exercises by Mirror Therapy in the Complex Regional Pain Syndrome of the Upper Limb : a Multicentric Randomized Open Study.

AlgoMIR project born thanks to a meeting between pain professionals and re-education staff. The goal of this project is to develop and evaluate a program of learning with exercises by mirror therapy, that could be easily shared with paramedic teams and easily adapted to different handicaps.

Researchers have chosen to select patients with re-education of the upper extremity to benefit from rehabilitation sessions either from physiotherapists present in their city, or of functional rehabilitation hospital units.

Read the detailed description

The Complex Regional Painful Syndromes (CRPS) called in the past aglodystrophia, are characterized by the apparition of pain abnormally spread and intensive compared to the initial causal factor. They are usually associated to negligence of the painful limb, and avoidance movements that require care in rehabilitation that it is carried out in the physiotherapist center or functional rehabilitation unit at hospital.

Recently, mirror therapy has been proposed to correct dysfunctions : patients have to realize a movement with their two hands, observing the reflect of their healthy hand in a mirror, while their painful hand is hidden behind the mirror. After a learning phase, patients have to continue this kind of therapy independently.

AlgoMIR project born thanks to a meeting between pain professionals and re-education staff. The goal of this project is to develop and evaluate a program of learning with exercises by mirror therapy, that could be easily shared with paramedic teams and easily adapted to different handicaps.

Researchers have chosen to select patients with re-education of the upper extremity to benefit from rehabilitation sessions either from physiotherapists present in their city, or of functional rehabilitation hospital units.

The primary outcome of this project is to compare analgesic effect at 8 and 16 weeks of a therapy mirror re-education program associated to a usual care (M+R), and of a usual care program (R).

A second goal is to understand eventual difficulties met by the patients and improve efficacy of the autonomous becoming of patients using mirror therapy.

Being tested
Mirror therapy, Usual care
Medical subject headings
Reflex Sympathetic Dystrophy, Causalgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mirror therapyBehavioural

    The intervention is a mirror therapy. The mirror therapy consists in performing some movements with a mirror, the hand that is painful is hidden and the image of the healthy hand is reflected in the mirror. Patients looking at this image seems to see their painful hand moving.

  • Usual careBehavioural

    Patients will have the usual care as an intervention.

Study groups in NCT02667717
Study groupRoleWhat they receive
Experimental group : Mirror TherapyExperimentalExperimental group will perform mirror therapies during 16 weeks, added to the usual care. Therapy mirror sessions will take place at hospital units but also at home.
Receives: Behavioral: Mirror therapy; Behavioral: Usual care
Control group : Usual careActive comparatorThe control group will benefit from the usual care during 16 weeks. No mirror therapies will be performed to this group.
Receives: Behavioral: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Compare the Visual Analogue Scale (EVA) of pain

    Compare after 8 weeks the score of EVA of pain in the last 24 hours for patients who performed during 8 weeks :

    • a program of mirror therapy associated with the usual care (M+R) or
    • the usual care without mirror therapy

    Measured: Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2016 (estimated)
  2. Study start6 Jun 2017
  3. Primary completion6 Jun 2019
  4. Study completion6 Jun 2019

Why it stopped: difficulties in including patients

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02667717
Sponsor's protocol ID
1508193
Other IDs
2016-A00088-43
Acronym
AlgoMIR
Status last verified
Jan 2021
First submitted
26 Jan 2016
Last updated
20 Jan 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mirror therapy in people with Reflex Sympathetic Dystrophy and Causalgia, run by Centre Hospitalier Universitaire de Saint Etienne at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 20 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: difficulties in including patients). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Compare the Visual Analogue Scale (EVA) of pain (time frame: Week 8). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in